Professor Costantino Pitzalis Honoured with Prestigious ACR Master Designation and Presents Breakthrough Research at ACR 2026
The Centre for Experimental Medicine & Rheumatology (EMR) at Queen Mary University of London is proud to announce that Professor Costantino Pitzalis has been conferred as a Master of the American College of Rheumatology (MACR) for 2026. The designation of Master is one of the highest honours bestowed by the American College of Rheumatology. It is awarded to distinguished members age 65 or older who have made outstanding, lifelong contributions to the ACR and the field of rheumatology through scholarly achievement, clinical innovation, and dedication to education and service.
Date added: Saturday, November 7, 2026
SQUEEZE General Assembly 2026 in Leiden
Members of the QMUL EMR team recently attended the SQUEEZE Year 4 Consortium and General Assembly Meeting in Leiden. The two-day event brought together project partners and patient representatives to review recent progress, discuss ongoing initiatives, and align on upcoming project priorities as the consortium works toward its final stretch leading into 2027.
Date added: Monday, October 13, 2025
EMR Achieves LEAF Silver Accreditation
The Centre for Experimental Medicine and Rheumatology (EMR) is proud to announce that our laboratory spaces have officially been awarded the Silver Award under the Laboratory Efficiency Assessment Framework (LEAF) for July 2026. This achievement highlights our team's ongoing commitment to reducing our environmental impact while maintaining world-class research standards.
Date added: Monday, July 6, 2026
Queen Mary University of London has approved the world’s first MSc in Precision Musculoskeletal Sciences, launching in September 2026
Date added: Friday, January 30, 2026
NIHR Barts BRC Celebrates Its Second Musculoskeletal Research Day
On 20th September 2025, we welcomed patients and their families to the NIHR Barts Biomedical Research Centre’s (BRC) second Musculoskeletal Day, following the success of last year’s inaugural event.
Date added: Tuesday, March 24, 2026
Queen Mary University of London is playing a key role in major new European research initiative to combat Multi-Drug Resistant Rheumatoid Arthritis (MDR-RA)
Date added: Wednesday, January 29, 2025
AutoPiX Project Celebrates European Patent Grant to Singularity Biomed for its AI Thermal-Imaging Technology
Date added: Monday, June 15, 2026
3TR Annual Meeting 2026: Advancing Cross-Disease Research
The 3TR consortium hosted its 7th Annual Meeting from 8–9 October 2026 at the University of Cagliari in Sardinia, bringing together leading researchers, clinicians, industry partners, and patient representatives from across Europe. Professor Costantino Pitzalis attended the two-day event, joining European colleagues to review scientific progress, explore data across disease boundaries, and align strategic priorities for cross-disease research and treatment success. For full details, visit the official 3TR News & Media updates. (Photo source: 3TR)
Date added: Monday, October 12, 2026